Feng Ru, Liu Dai-Hong, Xu Lan-Ping, Chen Huan, Zhang Xiao-Hui, Han Wei, Zhao Ting, Liu Kai-Yan, Huang Xiao-Jun
Institute of Hematology, Peking University, People Hospital, Beijing 100044, China.
Zhonghua Xue Ye Xue Za Zhi. 2010 Nov;31(11):732-5.
To analyze the characteristics and the number of organs involved in acute graft-versus-host disease (aGVHD) among different donors of allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Clinical data were retrospectively analyzed in 289 patients received allo-HSCT in our hospital, between November 2007 and December 2008. Clinical features of the involved organs between different donors were compared.
The cumulative incidence of aGVHD was 57.4% (166/289), grades I-II and grades III-IV were 52.1% and 11.0%, respectively. Skin was involved in 116 (69.9%) of the total 166 cases, gut 97 (47.6%), and liver 25(15.1%). Organs involved in HLA-identical sibling transplantation and in haplo-identical ones were skin 19 (42.2%), gut 25 (55.6%), and liver 12 (26.7%), and 79 (80.2%), 54 (44.6%) and 13 (10.7%) respectively. More aGVHD involvements of skin were found in HLA haplo-identical HSCT than in HLA identical sibling HSCT (P = 0.000). The involvement of skin grade II was 8(17.8%) and 38.8% (P = 0.01), gut grade II was 22 (48.9%) and 36 (29.8%) (P = 0.028) in HLA identical sibling transplantation and in haploidentical HSCT, repectively. The incidences of aGVHD grades I to II and grade III to IV were 103 (62.0%) versus 12 (7.2%) in the single organ involved group, 37 (22.3%) versus 11 (6.6%) in the double organs involved group, and 0% versus 3 (1.8%) in the triple organs involved group.
The percentage of aGVHD with skin involvement in haploidentical HSCT is significantly higher than that in HLA identical HSCT. There is a significant difference in mild skin or GI aGVHD between HLA matched and mismatched HSCT, but no difference in severe skin or GI aGVHD between the two groups. The percentage of severe aGVHD was higher if three organs were involved.
分析异基因造血干细胞移植(allo-HSCT)不同供者中急性移植物抗宿主病(aGVHD)的特征及受累器官数量。
回顾性分析2007年11月至2008年12月在我院接受allo-HSCT的289例患者的临床资料。比较不同供者中受累器官的临床特征。
aGVHD的累积发生率为57.4%(166/289),Ⅰ-Ⅱ级和Ⅲ-Ⅳ级分别为52.1%和11.0%。166例患者中,116例(69.9%)皮肤受累,97例(47.6%)肠道受累,25例(15.1%)肝脏受累。在HLA全相合同胞移植和单倍型相合移植中,受累器官分别为皮肤19例(42.2%)、肠道25例(55.6%)、肝脏12例(26.7%),以及皮肤79例(80.2%)、肠道54例(44.6%)、肝脏13例(10.7%)。单倍型相合HSCT中皮肤aGVHD受累比HLA全相合同胞HSCT更多(P = 0.000)。在HLA全相合同胞移植和单倍型相合HSCT中,皮肤Ⅱ级受累分别为8例(17.8%)和38.8%(P = 0.01),肠道Ⅱ级受累分别为22例(48.9%)和36例(29.8%)(P = 0.028)。单器官受累组aGVHDⅠ至Ⅱ级和Ⅲ至Ⅳ级的发生率分别为103例(62.0%)和12例(7.2%),双器官受累组分别为37例(22.3%)和11例(6.6%),三器官受累组分别为0%和3例(1.8%)。
单倍型相合HSCT中皮肤受累的aGVHD百分比显著高于HLA全相合HSCT。HLA配型相合和不相合的HSCT在轻度皮肤或胃肠道aGVHD方面存在显著差异,但两组在重度皮肤或胃肠道aGVHD方面无差异。三器官受累时重度aGVHD的百分比更高。